← Back to Search

N/A

Single Leg Immobilization for Muscle Atrophy

N/A

Recruiting

Research Sponsored by McGill University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 7 days

Awards & highlights

Study Summary

This trial will help researchers understand if there are differences in how men and women's bodies react to muscle atrophy.

Eligible Conditions

Muscle Atrophy
Muscle Wasting

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 7 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 7 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 7 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Fractional muscle protein synthesis rate

Secondary outcome measures

Muscle size

Muscle strength

Protein abundance and phosphorylation

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Group I: Single Leg Immobilization - MalesExperimental Treatment1 Intervention

Males will be subjected to 7-days of single-leg immobilization.

Group II: Single Leg Immobilization - FemalesExperimental Treatment1 Intervention

Females will be subjected to 7-days of single-leg immobilization.

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

McGill UniversityLead Sponsor

394 Previous Clinical Trials

998,351 Total Patients Enrolled

Media Library

Single Leg Immobilization (N/A) Clinical Trial Eligibility Overview. Trial Name: NCT05314413 — N/A

Muscle Atrophy Research Study Groups: Single Leg Immobilization - Males, Single Leg Immobilization - Females

Muscle Atrophy Clinical Trial 2023: Single Leg Immobilization Highlights & Side Effects. Trial Name: NCT05314413 — N/A

Single Leg Immobilization (N/A) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05314413 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What criteria must individuals fulfill to join this experiment?

"In order to qualify for participation in this trial, applicants must possess muscular tissue and be between 18-35 years old. Currently, the research team is seeking 30 volunteers."

Answered by AI

How many subjects are involved in this clinical experiment?

"Affirmative. Clinicaltrials.gov has the details, which indicate that this research is recruiting currently. First posted on May 1st 2022 and most recently updated June 13th 2022, 30 subjects are needed to complete the trial at one medical centre."

Answered by AI

Is there still room to enroll volunteers in this research endeavor?

"Affirmative. According to clinicaltrials.gov, this research project has been actively recruiting since May 1st 2022 and is still searching for participants. The trial intends to welcome 30 patients at a single medical site."

Answered by AI

Is this clinical trial open to individuals aged 55 and above?

"This medical trial is available to patients aged 18 to 35. Meanwhile, there are 49 trials for those younger and 155 studies catered towards elderly individuals above the age of 65."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Examining Sex-based Differences in Metabolic and Mechanistic Responses to Disuse Induced Muscle Atrophy

Tyler Churchward-Venne 2022. "Examining Sex-based Differences in Metabolic and Mechanistic Responses to Disuse Induced Muscle Atrophy". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05314413.